Skip to main content
Article
Tacrolimus, MMF, Steroid, and ALG Immunotherapy for High Immunological Risk Renal Transplant Recipients
Transplantation Proceedings (2001)
  • J. Zaltzman
  • Vivian McAlister
  • D. Russell
  • P. Halloran, University of Alberta
  • D. Landsberg
  • S. Busque
  • A. Shoker
  • A. Boucher
  • J. Shapiro
  • J. Tchervenkov
  • J. Peets
Keywords
  • Combined Modality Therapy,
  • Graft Rejection,
  • Immunosuppressive Agents,
  • Kidney Transplantation,
  • Mycophenolic Acid,
  • Tacrolimus
Disciplines
Publication Date
February, 2001
Publisher Statement
Dr. Vivian McAlister is currently a faculty member at The University of Western Ontario.
Citation Information
J. Zaltzman, Vivian McAlister, D. Russell, P. Halloran, et al.. "Tacrolimus, MMF, Steroid, and ALG Immunotherapy for High Immunological Risk Renal Transplant Recipients" Transplantation Proceedings Vol. 33 Iss. 1-2 (2001)
Available at: http://works.bepress.com/vivianmcalister/89/